Eye Disease News and Research

RSS
Eye diseases are widespread around the globe. According to the World Health Organization, the most important three eye diseases or conditions that are a potential threat to the global population are diabetic retinopathy, glaucoma, and age-related macular degeneration. One more vital reason for visual harm is refractive errors. Some of the important reasons for vision loss or low vision are age, healthcare, gender, genetic problems and the prevalence of family history.
Scientists discover novel compound to combat age-related blindness

Scientists discover novel compound to combat age-related blindness

Long-term antiviral treatment may protect vision from shingles

Long-term antiviral treatment may protect vision from shingles

Long-term low-dose antiviral treatment reduces eye disease risk from shingles

Long-term low-dose antiviral treatment reduces eye disease risk from shingles

Major donation fuels advances in ophthalmic artificial intelligence

Major donation fuels advances in ophthalmic artificial intelligence

Laughter is as good as eye drops in soothing dry eyes, study finds

Laughter is as good as eye drops in soothing dry eyes, study finds

New research aims to target IL-6 for treating diabetic retinopathy

New research aims to target IL-6 for treating diabetic retinopathy

Laughter exercise could be an initial treatment for relieving dry eye disease symptoms

Laughter exercise could be an initial treatment for relieving dry eye disease symptoms

$3.3 million study to explore eye health in patients with prediabetes and diabetes

$3.3 million study to explore eye health in patients with prediabetes and diabetes

Advanced imaging reveals hidden vision loss in AMD

Advanced imaging reveals hidden vision loss in AMD

New robot system used to improve treatment for debilitating eye disease

New robot system used to improve treatment for debilitating eye disease

Teprotumumab shows long-lasting benefits for thyroid eye disease patients

Teprotumumab shows long-lasting benefits for thyroid eye disease patients

Thyroid eye disease patients experience lasting improvements after treatment with teprotumumab

Thyroid eye disease patients experience lasting improvements after treatment with teprotumumab

Exonate appoints Dr Rafiq Hasan as Non-Executive Director

Exonate appoints Dr Rafiq Hasan as Non-Executive Director

Men face higher risk of diabetes complications than women, study finds

Men face higher risk of diabetes complications than women, study finds

Imaging using fundus autofluorescence can facilitate the diagnosis and monitoring of rare eye diseases

Imaging using fundus autofluorescence can facilitate the diagnosis and monitoring of rare eye diseases

Researchers aim to use AI for early screening and prognosis of Dry Eye Disease

Researchers aim to use AI for early screening and prognosis of Dry Eye Disease

Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation

Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

Gut bacteria may be responsible for sight loss in certain inherited eye diseases

Gut bacteria may be responsible for sight loss in certain inherited eye diseases

Novel genetic locations associated with primary open-angle glaucoma identified

Novel genetic locations associated with primary open-angle glaucoma identified

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.